Yield10 Bioscience, Inc. (YTENQ)
OTCMKTS · Delayed Price · Currency is USD
0.0150
0.00 (0.00%)
Mar 28, 2025, 4:00 PM EST

Yield10 Bioscience Statistics

Total Valuation

YTENQ has a market cap or net worth of 11,016. The enterprise value is 2.04 million.

Market Cap 11,016
Enterprise Value 2.04M

Important Dates

The last earnings date was Tuesday, March 11, 2025.

Earnings Date Mar 11, 2025
Ex-Dividend Date n/a

Share Statistics

YTENQ has 734,408 shares outstanding. The number of shares has increased by 137.43% in one year.

Current Share Class n/a
Shares Outstanding 734,408
Shares Change (YoY) +137.43%
Shares Change (QoQ) +23.90%
Owned by Insiders (%) 17.17%
Owned by Institutions (%) 0.19%
Float 608,276

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.01
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -0.16
EV / Sales 2.72
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -0.35

Financial Position

The company has a current ratio of 0.16

Current Ratio 0.16
Quick Ratio 0.10
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -0.47
Interest Coverage -331.39

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -178.11%
Return on Invested Capital (ROIC) -2,867.26%
Return on Capital Employed (ROCE) 267.88%
Revenue Per Employee 25,862
Profits Per Employee -438,000
Employee Count 29
Asset Turnover 0.17
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -99.83% in the last 52 weeks. The beta is 0.40, so YTENQ's price volatility has been lower than the market average.

Beta (5Y) 0.40
52-Week Price Change -99.83%
50-Day Moving Average 0.01
200-Day Moving Average 0.70
Relative Strength Index (RSI) 29.90
Average Volume (20 Days) 706

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.01

Income Statement

In the last 12 months, YTENQ had revenue of 750,000 and -12.70 million in losses. Loss per share was -24.93.

Revenue 750,000
Gross Profit -6.46M
Operating Income -12.59M
Pretax Income -12.70M
Net Income -12.70M
EBITDA -12.32M
EBIT -12.59M
Loss Per Share -24.93
Full Income Statement

Balance Sheet

The company has 733,000 in cash and 2.76 million in debt, giving a net cash position of -2.03 million or -2.76 per share.

Cash & Cash Equivalents 733,000
Total Debt 2.76M
Net Cash -2.03M
Net Cash Per Share -2.76
Equity (Book Value) -6.24M
Book Value Per Share -9.71
Working Capital -6.47M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -5.80 million and capital expenditures -19,000, giving a free cash flow of -5.82 million.

Operating Cash Flow -5.80M
Capital Expenditures -19,000
Free Cash Flow -5.82M
FCF Per Share -7.92
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -1,679.07%
Pretax Margin -1,693.60%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

YTENQ does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -137.43%
Shareholder Yield -137.43%
Earnings Yield -115,305.01%
FCF Yield -52,814.09%

Stock Splits

The last stock split was on May 3, 2024. It was a reverse split with a ratio of 0.0416667.

Last Split Date May 3, 2024
Split Type Reverse
Split Ratio 0.0416667

Scores

YTENQ has an Altman Z-Score of -214.14. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -214.14
Piotroski F-Score n/a